CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $709,240
- in 1 filing, $709K under 10b5-1 plans
Net −$709,240. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-19 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −100,000 | $7.09 | $709K | 0 |
| 2026-06-23 | Sauvage Philippe Chief Financial Officer | Sale 10b5-1 | −47,668 | $6.01 | $286K | 12,673 |
| 2026-06-23 | Markel Stacy CHIEF PEOPLE OFFICER | Sale 10b5-1 | −125,000 | $6.03 | $753K | 32,591 |
| 2026-06-23 | Wentworth Kerry CHIEF REGULATORY OFFICER | Sale 10b5-1 | −63,000 | $6.02 | $379K | 53,000 |
| 2026-04-17 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $5.02 | $251K | 18,000 |
| 2026-04-17 | Wentworth Kerry CHIEF REGULATORY OFFICER | Sale 10b5-1 | −36,750 | $5.01 | $184K | 53,000 |
| 2026-04-06 | Wentworth Kerry CHIEF REGULATORY OFFICER | Sale 10b5-1 | −200,000 | $4.52 | $904K | 53,000 |
| 2025-12-01 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | −150,000 | $7.82 | $1.2M | 18,000 |
| 2025-11-26 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | −10,000 | $8.00 | $80K | 18,000 |
| 2025-11-25 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | −10,000 | $7.50 | $75K | 18,000 |
| 2025-11-20 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | −20,000 | $7.00 | $140K | 18,000 |
| 2025-11-20 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Sale | −69,051 | $7.23 | $499K | 0 |
| 2025-11-20 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Sale | −300,000 | $7.23 | $2.2M | 0 |
| 2025-11-19 | Hanley David C. CHIEF TECHNICAL OPERATIONS | Sale | −200,000 | $7.14 | $1.4M | 24,000 |
| 2025-11-19 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | −15,000 | $5.10 | $77K | 18,000 |
| 2025-11-17 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | −15,000 | $4.77 | $71K | 15,000 |
| 2025-10-27 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −100,000 | $5.02 | $502K | 0 |
| 2025-05-02 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale 10b5-1 | −20,000 | $2.50 | $50K | 12,000 |
| 2024-11-11 | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | Sale | −56,361 | $2.89 | $163K | 3,866,228 |
| 2022-04-05 | Omega Fund V, L.P. 10% owner | Sale | −2,500,000 | $5.60 | $14.0M | 20,457,340 |
Page 1 of 2 · 29 trades